Human Papillomavirus Vaccination Prevalence and Disproportionate Cancer Burden Among US Veterans

JAMA Oncol. 2023 May 1;9(5):712-714. doi: 10.1001/jamaoncol.2022.7944.

Smrithi Chidambaram^{1

2

3}, Su-Hsin Chang^{3

4}, Vlad C Sandulache^{5

6

7}, Angela L Mazul^{1

4}, Jose P Zevallos^{8

9

10}

¹ Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri.
² Department of Otolaryngology-Head and Neck Surgery, St Louis University School of Medicine, St Louis, Missouri.
³ Research Service, St Louis Veterans Affairs (VA) Medical Center, St Louis, Missouri.
⁴ Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri.
⁵ Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
⁶ Ear, Nose, and Throat Section, Operative Care Line, Michael E. DeBakey VA Medical Center, Houston, Texas.
⁷ Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, Texas.
⁸ Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
⁹ Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
¹⁰ St Louis VA Medical Center, St Louis, Missouri.

No abstract available

Plain language summary

This cross-sectional study examines the rate of HPV vaccination and the number eligible for this vaccination among younger veterans and civilians.